EUVIMEDOpdag EUVIMED
Fallbericht

Lack of Rb and p53 Expression in a Case of CM2B4 Negative Merkel Cell Carcinoma In Situ Associated With Squamous Dysplasia

Austinn C Miller iD, Eric Delgado Rendon, Nathanial Branscome, Pamela Padilla, Stephen Richardson, David Dolson, András Schaffer

Journal of Cutaneous Pathology · 2026

DOI: 10.1111/cup.70073 ↗

At a glance

Fallbericht in Journal of Cutaneous Pathology, 2026. Written by Austinn C Miller and 6 co-authors. Institution: University of Central Florida HCA Florida Healthcare Graduate Medical Education, Tallahassee, Florida, USA. Major MEDLINE topics: Carcinoma, Merkel Cell, Tumor Suppressor Protein p53, Skin Neoplasms, Retinoblastoma Protein. Cited 2 times so far (Crossref); 35 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Merkel cell carcinoma (MCC) is a dermal neuroendocrine malignancy driven by inactivation of the tumor suppressors Rb and p53 either through Merkel cell polyomavirus (MCPyV) infection or ultraviolet (UV)‐induced mutations. Virus‐positive MCC exhibits pure neuroendocrine morphology, low UV‐induced mutational burden, retained Rb protein, and low p53 expression. Viral‐negative MCC includes pure neuroendocrine carcinomas and combined tumors with squamous and neuroendocrine components. These tumors typically exhibit loss of Rb expression and either overexpression of mutated p53 or a complete absence of p53. Intraepidermal, in situ MCC (MCCis) is a rare, primarily viral‐negative variant that often coexists with actinic keratosis (AK) and squamous cell carcinoma in situ (SCCis), supporting a UV‐driven pathogenesis. While MCCis is hypothesized as a potential precursor to select cases of combined MCC, its p53 and Rb expression remain largely uncharacterized. We report a CM2B4‐negative MCCis in an 87‐year‐old man associated with AK and SCCis. Compared to normal epidermis, AK and SCCis exhibited increased Rb and p53 expression, whereas MCCis demonstrated loss of expression of both tumor suppressors. These findings suggest that dual downregulation of Rb and p53 may drive select cases of MCCis in sun‐damaged skin.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Merkel CellTumor Suppressor Protein p53Skin NeoplasmsRetinoblastoma ProteinHumansMaleAged, 80 and overNon-Melanoma Skin NeoplasmsKeratosis, ActinicCarcinoma, Squamous CellCutaneous Squamous Cell Carcinoma

Author keywords

MCPyVMerkel cell carcinomaMerkel cell carcinoma in situRbintraepidermal Merkel cell carcinomap53

Substances

Tumor Suppressor Protein p53TP53 protein, humanRetinoblastoma Protein

Authors and institutions

  • University of Central Florida HCA Florida Healthcare Graduate Medical Education, Tallahassee, Florida, USA.
  • Dermatology Associates of Tallahassee, Tallahassee, Florida, USA.
  • Florida State University College of Medicine, Tallahassee, Florida, USA.
  • Boston University School of Medicine, Boston, Massachusetts, USA.
  • Inform Diagnostics, Needham, Massachusetts, USA.

ORCID profiles: Austinn C Miller

Cite

APA

Miller, A. C., Rendon, E. D., Branscome, N., Padilla, P., Richardson, S., Dolson, D., & Schaffer, A. (2026). Lack of Rb and p53 Expression in a Case of CM2B4 Negative Merkel Cell Carcinoma In Situ Associated With Squamous Dysplasia. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.70073

Vancouver

Miller AC, Rendon ED, Branscome N, Padilla P, Richardson S, Dolson D, et al. Lack of Rb and p53 Expression in a Case of CM2B4 Negative Merkel Cell Carcinoma In Situ Associated With Squamous Dysplasia. Journal of Cutaneous Pathology. 2026. doi:10.1111/cup.70073

BibTeX
@article{Miller2026,
  author = {Miller, Austinn C and Rendon, Eric Delgado and Branscome, Nathanial and Padilla, Pamela and Richardson, Stephen and Dolson, David and Schaffer, András},
  title = {Lack of Rb and p53 Expression in a Case of CM2B4 Negative Merkel Cell Carcinoma In Situ Associated With Squamous Dysplasia},
  journal = {Journal of Cutaneous Pathology},
  year = {2026},
  doi = {10.1111/cup.70073}
}
Start for free →